Hypocretin: a promising target for the regulation of homeostasis.

Front Neurosci · 2025 · PMC12415059 · PMID 40927422

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results indicated that Seltorexant holds the most promise for therapeutic efficacy in treating MDD, Suvorexant showed a trend toward improvement, while Filorexant yielded less favorable outcomes ( Meshkat et al., 2025 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.